CSI Market
Sign In | Register

Healthequity Inc (HQY) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access HQY quarterly Cash Flow →
The cash flow figures below highlight longer-term patterns in how Healthequity Inc manages cash inflows and outflows over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Jan 31 2026)
12 Months 		(Jan 31 2025) (Jan 31 2024) (Jan 31 2023) (Jan 31 2022)
Operating Activities
Income215.20
Depreciation & amortization154.66
Amortization of Other Assets1.06
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Intangible Assets0.00
Share-based Compensation73.06
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Increase Decrease In Operating Lease Right Of Use Asset6.79
Increase Decrease In Operating Lease Liability Noncurrent-8.00
Operating Lease Impairment Loss-
Income taxes39.73
Gain (Loss) on Sale of Investments0.00
Accounts Receivable-14.50
Increase (Decrease) in Accounts Payable0.00
Increase (Decrease) in Accrued Liabilities1.71
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-12.66
Other Working Capital0.05
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities457.09
Investing Activities
Capital Expenditures-48.78
Sale of Capital Items0.00
Proceeds from Sale of Available-for-sale Securities, Debt0.00
Short-term Investments Acq.0.00
Payments for (Proceeds from) Derivative Instrument, Investing Activities1.64
Proceeds From Sale Of Equity Securities Fv Ni-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-47.14
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-100.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-287.84
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds from Issuance Initial Public Offering Net of Offering Costs-
Proceeds from Issuanceor Sale of Equity Net of Offering Costs Paid-
Payments To Settle Client Held Funds-
Proceeds From Settlement Of Client Held Funds-
Payments For Proceeds From Settlement Of Client Held Funds0.87
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-386.98
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow408.32
Total Cash Flow22.98
4 historic quarters locked

Sign in to unlock the full Healthequity Inc cash flow history.

Sign In Create Free Account

About Healthequity Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20260131)
  • Filed with the SEC: March 17, 2026
  • Source: hqy-20260131.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001428336-26-000010

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License